Companies
Roche's Enspryng gets FDA Priority Review for rare MOGAD treatment
The FDA has granted Priority Review for Roche's satralizumab to treat MOGAD, an autoimmune disease with no approved therapies, based on Phase III data showing a 68% reduction in relapse risk.
HIVE Digital names Mark Volk revenue chief at BUZZ HPC unit
The bitcoin miner appoints the former IBM and HPE executive to lead go-to-market strategy as it shifts focus toward GPU cloud and AI infrastructure.
FDA grants priority review for Genentech's Enspryng in rare disease MOGAD
The U.S. regulator fast-tracked Genentech's application for enspyring in MOGAD, a rare autoimmune disorder with no approved treatments. A decision is expected by January 2027.
ABB and BCG report says DC technology set to become core of future power systems
ABB and Boston Consulting Group outline how direct‑current solutions will complement AC grids, driven by AI data centres, EVs and renewable integration, and call for standards and skills to speed adoption.
Amazon Pauses Operations With Cargo Operator 21Air After Deadly Miami Crash
Amazon.com suspended its partnership with 21Air following a cargo plane crash at Miami International Airport that killed five people.
Underwater Defense Race Spurs Investment in Sea Drones and Subsea Security
Governments and defense firms are funding autonomous underwater vehicles and sensor networks to protect critical seabed infrastructure amid rising concerns over hybrid warfare and sabotage.
Revolut Threat Actors Begin Posting Customer Data, Promise Daily Leaks
Attackers who obtained Revolut customer information via an impersonation scam have started publishing leaked data online and are threatening daily releases until the bank pays.
Lexeo Therapeutics reports gene therapy data at Cantor
Lexeo Therapeutics presented Phase I/II results for its LX2006 Friedreich’s ataxia gene therapy, showing a 28% LVMI reduction and mFARS improvement, and gave updates on its PKP2 and Alzheimer’s programs.
Ovid Therapeutics Outlines KCC2, Epilepsy Pipeline at Cantor Healthcare Conference
CEO Meg Alexander highlighted OV329 for treatment-resistant epilepsy and the OV4071 KCC2 program, citing a $1B+ opportunity even at single-digit market penetration.
Veru Highlights Muscle-Preserving Weight-Loss Data at Cantor Fitzgerald Healthcare Conference
Veru reported encouraging Phase IIb results combining enobosarm with semaglutide for older overweight patients, pointing to a PLATEAU readout expected early next year.
Okta Pitches Agentic Identity Strategy at Goldman Sachs Tech Conference
The identity-management company unveiled its AI-agent security framework, highlighted multimillion-dollar deals, and discussed a sales restructuring as it pivots toward the emerging agent market.
Alumis posts strong psoriasis results, lupus trial miss at Cantor conference
Alumis said its oral TYK2 inhibitor showed 40‑55% PASI‑100 responses in psoriasis studies, while its Phase IIb lupus trial failed to meet the primary endpoint, citing a high‑interferon‑negative subgroup.
Upwork Touts 174% Business Plus Growth, Lifts 2026 GSV View on AI Push
Freelance platform reports fastest-growing product in company history and increases full-year guidance as AI-integrated offerings accelerate adoption among midmarket clients.
CGI Prices C$500 Million Senior Unsecured Notes Offering
Montreal IT services firm raises C$497.3 million net from two series of senior notes at 4.2% and 4.5%, set to close Sept. 14 for debt repayment and general corporate use.
Larry Ellison cancels plan to sell Oracle stock
Larry Ellison has called off a planned sale of Oracle shares.
Mastercard Launches Wallet Pay for Cross-Border Digital Wallet Interoperability
Mastercard introduced Wallet Pay in Singapore, enabling digital wallets to interoperate across contactless, QR code, and online payments through its global network.
BKV Corporation Upsizes Convertible Notes Offering to $500 Million
Denver-based BKV raised the size of its convertible senior notes from $400M to $500M at 1.625% interest, maturing October 2031, with initial purchasers given a $75M option.
Nestlé’s Illegal Waste Deposits Case Reopens for New Trial
Swiss food giant faces fresh scrutiny over decades-old environmental violations in the Vosges Mountains
CoreWeave Prices $3.7 Billion Convertible Notes Offering
Cloud infrastructure provider upsizes convertible senior notes due 2033; offers capped call transactions to mitigate dilution.
Rogers Communications Prices $1.59 Billion in Subordinated Notes
The Canadian telecom issued $1 billion in U.S. notes and C$600 million in Canadian debt, with proceeds earmarked to redeem higher-maturing obligations.
Wetour Robotics spins off power infrastructure unit into Vantrapower LLC
Austin-based subsidiary targets Texas and North America’s growing demand for transformers and power infrastructure in data centers and energy projects
Quince Therapeutics Presents Inhaled Rapamycin Pipeline Data at Cantor Conference
Quince Therapeutics outlined its inhaled rapamycin program for lung transplant rejection and pulmonary hypertension at the Cantor Fitzgerald healthcare conference, with Phase II data expected next year.
Creative Medical Files Provisional Patent for Ultrasome Regenerative Medicine Platform
The company submitted a U.S. provisional patent application covering composition, manufacturing and therapeutic uses of its cell‑free Ultrasome platform, citing a pilot study in which about 93% of knee osteoarthritis patients showed meaningful improvement.
Dun & Bradstreet Adds Commercial Graph to IBM watsonx Orchestrate Catalog
The integration makes Dun & Bradstreet’s D&B Commercial Graph accessible via IBM’s watsonx Orchestrate Agent Catalog, supplying verified business identity data for AI-driven workflows.